Freestyle Libre 2
Payments companies reported to CMS as associated with Freestyle Libre 2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Freestyle Libre 2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Freestyle Libre 2
These are the largest totals companies reported as associated with Freestyle Libre 2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Bhakti Paul | Raleigh, NC | Internal Medicine | $14,381.86 |
| Alan Parsa | Honolulu, HI | Endocrinology, Diabetes & Metabolism | $6,075.00 |
| Robert Oberstein | Hartford, CT | Endocrinology, Diabetes & Metabolism | $4,675.32 |
| Grace Carlson | Berkeley, CA | Internal Medicine | $3,995.00 |
| Isaac Sachmechi | New Hyde Park, NY | Endocrinology, Diabetes & Metabolism | $3,649.29 |
| Eugene Wright | Fayetteville, NC | Internal Medicine | $3,049.37 |
| Sarah Fishman | New York, NY | Endocrinology, Diabetes & Metabolism | $2,770.60 |
| Nora Barsony | Tucson, AZ | Endocrinology, Diabetes & Metabolism | $2,653.16 |
| Sam Fereidouni | Scottsdale, AZ | Family Medicine | $2,388.37 |
| Monica Peek | Chicago, IL | Internal Medicine | $2,200.00 |
Prescribed Freestyle Libre 2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.